The Future of Microbiology Testing/Clinical Microbiology
The development of clinical microbiology is a response to clinical needs. This may take the form of technological innovation commonly derived from the OD of science or is a reflection of advances in anti-infective therapy seeking recognition of microbial etiology that now responds to therapeutic intervention. But this history is also a reflection of the political climate, of perceived threats to the more established organizational and professional institutions by an emerging field. While this conflict influenced the development of clinical microbiology as a distinguishing feature, it is sufficiently controversial to be extracted from this essay.
WANT TO KNOW MORE - DOWNLAOD SAMPLE PDF
Medical microbiology begins with a review of the immune system, focusing on the body's response to invading microorganisms. Bacteria are covered, first with a series of chapters introducing general concepts of bacterial microbiology and then with chapters detailing the major bacterial pathogens of humans. Similar classes include virology, mycology and parasitology. In each section, the introductory chapters emphasize the mechanisms of infection characteristic of that type of microorganism, thus providing a framework for the reader to understand rather than remember the clinical behavior of pathogens. The last section of the book introduction is organized by infectious diseases, organ system and provides the infection for clinical considerations.
Microbiology testing/clinical microbiology is a discipline that incorporates with the testing for microorganisms. On the other hand, the clinical microbiology focused on medical science which is concerned with the prevention, diagnosis and treatment of infectious diseases. The microbiology testing/clinical microbiology is used for the rapid identification of the microorganism and for the treatment of the infectious diseases caused by bacteria, fungus, viruses, parasites and other microorganism.
Download Sample PDF Brochure
The List of Companies working in this study
1. Merck KGaA
2. Hologic Inc.
3. F. Hoffmann-La Roche Ltd
4. Thermo Fisher Scientific Inc.
5. 3M
6. BD
7. Danaher
8. Shimadzu Corporation
9. bioMĂ©rieux SA
10. Bio-Rad Laboratories, Inc.
Since the 1960s, many micro-innovations have been introduced and used in clinical microbiology laboratories. Paternally, none of them allowed microbiologists to relinquish the dogma of pure culture techniques, to avoid the need to study microorganisms under the most unnatural conditions, or with laboratory variants of organisms encountered in natural settings to work. Molecular biology techniques promise a revolution in the diagnosis of infectious disease - a promise still in its infancy.
North America is expected to dominate the microbiology testing / clinical microbiology industry due to the increasing incidence of infectious diseases in the global arena, public-private investment in life sciences research, and increased funding in the field. However, the Asia-Pacific region is projected to show a significant growth rate over the next few years in the global microbiology testing / clinical microbiology industry due to the adoption of advanced technology and increasing awareness of the benefits of testing technologies in the region.
Microbiology Testing / Clinical Microbiology industry report analyzes the factors influencing the industry from both demand and supply side and evaluates the industry dynamics affecting the industry during the forecast period i.e. drivers, restraints, opportunities and future trend . This report provides complete pest analysis for all five regions; North America, Europe, APAC, MEA and South and Central America after evaluating the political, economic, social and technological factors affecting the industry in these regions.
WANT TO KNOW MORE - DOWNLAOD SAMPLE PDF
The industry for microbiology testing / clinical microbiology is expected to grow significantly in the coming years, due to major factors such as increased hospital-acquired infections and fungal infections in immune-compromised and pathogen discovery worldwide. In addition, increasing technological advances in disease diagnosis are likely to add new opportunities for the global medical holography industry over the forecast period.